FDA Webview Site FDA Review Site FDA Updater Site
header.gif
Username:
Password:
 

human drugs
animal drugs
biologics
eirs 483s
medical devices
marketing
email
search our site
  
FDA-RELATED NEWS
 
 
 
TXT FDA Enforcement Drops Under Trump Administration
01/08/2018
 
 
TXT FDA Sets 4 Strategic Policy Priorities
01/11/2018
 
 
TXT CDER Easing Bioequivalence for Inhaled Drugs
01/12/2018
 
 
TXT Data Volume, Diversity Slow Drug Development: Study
01/09/2018
 
 
TXT FDA Delays ‘Intended Use’ Changes to Review Stakeholder Concerns
01/12/2018
 
 
TXT Public Citizen Seeks Ban on HES Intravenous Solutions
01/12/2018
 
 
TXT Founder of FDA Device Bureau, David Link Dies at 87
01/11/2018
 
 
TXT Expedited Pathways Getting Good Use: Woodcock
01/10/2018
 
 
TXT Guide on Device UDI Enforcement
01/12/2018
 
 
TXT Warning Letter Issued to Becton Dickinson
01/11/2018
 
 
TXT FDA Panel Votes Down Lipocine Testosterone Product
01/11/2018
 
 
TXT FDA Orders Cough Medicine Labeling Changes
01/11/2018
 
 
TXT Mixed Social Media Use of Drug Safety Communications
01/10/2018
 
 
TXT FDA Enforcement Emphasis to Continue: Sklamberg
01/10/2018
 
 
TXT Product Approval Summaries
01/15/2018
 
 
TXT Since Our Last Issue ...
01/15/2018
 
 
TXT Latest Federal Register Notices
01/15/2018
 
 
TXT Endo Oxymorphone Documents Subpoenaed
01/11/2018
 
 
TXT FDA Asks Court to Deny Orenitram Exclusivity
01/11/2018
 
 
TXT Edwards Recalls Certitude Delivery System
01/11/2018
 
 
TXT FDA Feeding Tube Placement Letter
01/11/2018
 
 
TXT Journal Investigates Vaccine Study
01/11/2018
 
 
TXT Groups Fault Trial Reporting, Want Full Info Published
01/11/2018
 
 
TXT Policy Issues in Drug Compounding Debate
01/10/2018
 
 
TXT Judge Reverses $27.8 Million Xarelto Award
01/10/2018
 
 
TXT CBER Approved Therapeutic ‘Firsts’ in FY 2017
01/09/2018
 
 
TXT Latest FDA Warning Letters
01/09/2018
 
 
TXT Supreme Court Asked to Consider ‘Materiality’ Standard
01/09/2018
 
 
TXT WLF Asks Supreme Court to Overturn 3rd Circuit Decision
01/09/2018
 
 
TXT Gottlieb Praises Drug Approvals, Other 2017 Successes
01/09/2018
 
 
 
 
The most authoritative FDA news analysis each week is found in the pages of Dickinson's FDA Review. Since 1984, this newsletter has been providing in-depth reports on the most significant FDA developments affecting the pharmaceutical, medical device, biologics and veterinary medicines industries. Unlike other media, FDA Review eliminates time-wasting minutia and presents in clear, concise language the essence of what's really important - and why. It is the publication that FDA officials themselves read. Delivered in the middle of each week, FDA Review presents:
  • The latest agency policy developments, often before they're officially announced;
  • Major news insights, follow-ups and reactions in each product area;
  • Summaries of the latest Warning Letters;
  • The newest product approvals;
  • Summaries of the latest FDA Federal Register notices;
  • Summaries of DDMAC letters;
  • Related industry news capsules;
  • The industry's most concise FDA news index;
  • Inside-FDA news briefs
You can rely on FDA Review to provide only what's important - in the most convenient and time-saving